7-135164952-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018295.5(TMEM140):āc.511T>Cā(p.Phe171Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000411 in 1,459,046 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_018295.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM140 | NM_018295.5 | c.511T>C | p.Phe171Leu | missense_variant | 2/2 | ENST00000275767.3 | NP_060765.4 | |
CYREN | NM_001305630.2 | c.174+3797A>G | intron_variant | NP_001292559.1 | ||||
CYREN | XM_017012595.2 | c.*40+2780A>G | intron_variant | XP_016868084.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM140 | ENST00000275767.3 | c.511T>C | p.Phe171Leu | missense_variant | 2/2 | 1 | NM_018295.5 | ENSP00000275767.2 | ||
CYREN | ENST00000459937.5 | n.356+3797A>G | intron_variant | 1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1459046Hom.: 0 Cov.: 33 AF XY: 0.00000276 AC XY: 2AN XY: 725360
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 09, 2024 | The c.511T>C (p.F171L) alteration is located in exon 2 (coding exon 1) of the TMEM140 gene. This alteration results from a T to C substitution at nucleotide position 511, causing the phenylalanine (F) at amino acid position 171 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at